Opinion

Video

Safety and Efficacy of HER2-Directed ADCs for NSCLC

Panelists discuss how the selection between fam-trastuzumab deruxtecan-nxki and ado-trastuzumab emtansine is guided by findings from pivotal trials like DESTINY-Lung01 and DESTINY-Lung02, real-world patient outcomes compared with clinical trial results, and the management of common treatment-related adverse events associated with these HER2-directed therapies.

Video content above is prompted by the following:

  • What factors guide the choice between fam-trastuzumab deruxtecan-nxki and ado-trastuzumab emtansine?
  • What key insights emerged from pivotal trials like the phase 2 basket DESTINY-Lung01and DESTINY-Lung02?
  • How do real-world patient outcomes compare with those seen in clinical trials?
  • What are the most common treatment-related adverse events observed with HER2-directed therapies, and how are they managed?

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
4 KOLs are featured in this series
Related Content
Palliative care | Image Credit: Chinnapong - stock.adobe.com
November 22nd 2024

Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer

Brooke McCormick
Initiating palliative care more than 3 months before death improves end-of-life outcomes for patients with ovarian cancer, highlighting the need for earlier interventions.
Managed Care Cast
October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi
Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.
BMI - Olivier Le Moal
November 21st 2024

Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link

Kimberly Rath, PharmD
A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Managed Care Cast logo
July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Closeup of hand with cardiogram on red heart | Image Credit: Syda Productions - stock.adobe.com
November 21st 2024

Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk

Brooke McCormick
Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
WINSTON KIRTON, JD | Image credit: Courtesy of Winston Kirton
November 20th 2024

As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?

Ryan Flinn Mary Caffrey

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo